院外心脏骤停后目标温度管理的治疗范围内时间与结局
本研究为回顾性队列研究,基于Resuscitation Outcomes Consortium-持续胸外按压试验,纳入接受TTM>12小时的成人院外心脏骤停患者2637例(平均年龄62.3岁,女性29.9%)。采用线性插值法计算32°C-36°C等多个目标温度的治疗范围内时间(TTR)。风险校正分析显示,32°C-36°C的TTR与出院生存(OR 1.00 [95%CI 0.90-1.10])或良好神经功能结局(OR 1.02 [95%CI 0.90-1.14])均无关联;而33°C-36°C的TTR与良好神经功能生存显著相关(OR 1.12 [95%CI 1.01-1.25]),但与总生存无关(OR 1.04 [95%CI 0.94-1.15])。
要点
- 2637例院外心脏骤停后接受TTM>12小时的患者中,32°C-36°C的TTR中位时间为23小时(IQR 21-24),治疗范围外时间中位仅0.9小时(IQR 0.0-4.2)。
- 风险校正后,32°C-36°C的TTR与出院生存无关(OR 1.00 [95%CI 0.90-1.10]),与良好神经功能结局也无关(OR 1.02 [95%CI 0.90-1.14])。
- 33°C-36°C的TTR与良好神经功能生存显著相关(OR 1.12 [95%CI 1.01-1.25]),但与总生存无关(OR 1.04 [95%CI 0.94-1.15])。
- 作者认为,在特定温度阈值下,TTR与良好神经功能结局相关,但TTR与总生存无关。
适用人群与场景
- 成人院外心脏骤停后接受目标温度管理(TTM)超过12小时的患者。
- 数据来源于Resuscitation Outcomes Consortium-持续胸外按压试验。
诊断标准与关键阈值
- 指南推荐的目标温度管理目标温度为32°C-36°C,持续时间至少24小时。
研究设计与关键结果
- 研究类型:回顾性队列研究,基于Resuscitation Outcomes Consortium-持续胸外按压试验。
- 样本量:2637例,平均年龄62.3岁,女性占29.9%。
- 方法:对连续温度测量值采用线性插值法填补,计算多个目标温度的治疗范围内时间(TTR),采用分层回归模型评估TTR与出院生存及良好神经功能结局的关联。
- 32°C-36°C的TTR中位持续时间为23小时(IQR 21-24),治疗范围外时间中位为0.9小时(IQR 0.0-4.2)。
- 风险校正分析:32°C-36°C的TTR与总生存无关(OR 1.00 [95%CI 0.90-1.10]),与良好神经功能结局无关(OR 1.02 [95%CI 0.90-1.14])。
- 33°C-36°C的TTR与良好神经功能生存显著相关(OR 1.12 [95%CI 1.01-1.25]),与总生存无关(OR 1.04 [95%CI 0.94-1.15])。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论未据此给出推荐;作者认为,在特定温度阈值下,TTR与良好神经功能结局相关,但TTR与总生存无关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: For comatose survivors of out-of-hospital cardiac arrest (OHCA), current guidelines recommend targeted temperature management (TTM) with a goal temperature of 32 °C-36 °C for at least 24 h. We examined adherence to temperature targets, quantified as time-in-therapeutic range (TTR), and association of TTR with survival and neurologic outcomes.
METHODS: We conducted a retrospective cohort study of the Resuscitation Outcomes Consortium-Continuous Chest Compressions trial, including adults with OHCA who underwent TTM for >12 h. We imputed continuous temperatures between consecutive temperature measurements using the linear interpolation method and calculated TTR for multiple target temperatures. The association of TTR with survival to hospital discharge and favorable neurological outcome was evaluated using hierarchical regression models.
MAIN RESULTS: Among 2,637 patients (mean age 62.3 years, 29.9 % female), the median duration of TTR for TTM between 32 °C-36 °C was 23 (IQR: 21-24) hours with a median time outside therapeutic range of 0.9 (IQR: 0.0-4.2) hours. In risk-adjusted analyses, there was no association of TTR of 32 °C-36 °C with overall survival (OR 1.00 [95 % CI, 0.90-1.10]) or favorable neurologic outcome (1.02 [95 % CI, 0.90-1.14]). However, in assessments of TTR 33 °C-36 °C, there was a significant association with favorable neurologic survival (OR 1.12 [1.01-1.25]) but not overall survival (OR 1.04 [0.94-1.15]).
CONCLUSIONS: Among patients with OHCA who underwent TTM, we found variability in adherence to guideline-recommended treatment targets. Higher TTR was not associated with overall survival, but for certain temperature thresholds, TTR was associated with favorable neurologic outcome.
参考来源
- Wheelock KM, Chan PS, Chen L, et al. Time in therapeutic range for targeted temperature management and outcomes following out-of-hospital cardiac arrest. Resuscitation. 2022. PMID: 36442596. doi:10.1016/j.resuscitation.2022.11.016
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。